122 related articles for article (PubMed ID: 8939385)
1. Cytometric analysis and maturation characteristics of reticulocytes from myelodysplastic patients.
Bowen D; Williams K; Phillips I; Cavill I
Clin Lab Haematol; 1996 Sep; 18(3):155-60. PubMed ID: 8939385
[TBL] [Abstract][Full Text] [Related]
2. Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters.
Bowen DT; Culligan D; Beguin Y; Kendall R; Willis N
Leukemia; 1994 Jan; 8(1):151-5. PubMed ID: 8289479
[TBL] [Abstract][Full Text] [Related]
3. Reticulocyte maturity as an indicator for estimating qualitative abnormality of erythropoiesis.
Watanabe K; Kawai Y; Takeuchi K; Shimizu N; Iri H; Ikeda Y; Houwen B
J Clin Pathol; 1994 Aug; 47(8):736-9. PubMed ID: 7962628
[TBL] [Abstract][Full Text] [Related]
4. What is ineffective erythropoiesis in myelodysplastic syndromes?
Bowen D
Leuk Lymphoma; 1995 Jul; 18(3-4):243-7. PubMed ID: 8535189
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic syndrome with prolonged reticulocyte survival mimicking hemolytic disease.
Sher GD; Pinkerton PH; Ali MA; Senn JS
Am J Clin Pathol; 1994 Feb; 101(2):149-53. PubMed ID: 8116568
[TBL] [Abstract][Full Text] [Related]
6. Ratio of bone marrow reticulocytes to peripheral corrected reticulocytes for evaluating ineffective erythropoiesis.
Choi JW
Ann Clin Lab Sci; 2006; 36(4):439-41. PubMed ID: 17127730
[No Abstract] [Full Text] [Related]
7. Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes.
Musto P; Modoni S; Alicino G; Savino A; Longo A; Bodenizza C; Falcone A; D'Arena G; Scalzulli P; Perla G
Haematologica; 1994; 79(6):493-9. PubMed ID: 7896207
[TBL] [Abstract][Full Text] [Related]
8. Utility of reticulocyte maturation parameters in the differential diagnosis of macrocytic anemias.
Torres Gomez A; Casaño J; Sánchez J; Madrigal E; Blanco F; Alvarez MA
Clin Lab Haematol; 2003 Oct; 25(5):283-8. PubMed ID: 12974717
[TBL] [Abstract][Full Text] [Related]
9. Uncoupling of CD71 shedding with mitochondrial clearance in reticulocytes in a subset of myelodysplastic syndromes.
Zhang Q; Steensma DP; Yang J; Dong T; Wu MX
Leukemia; 2019 Jan; 33(1):217-229. PubMed ID: 30050123
[TBL] [Abstract][Full Text] [Related]
10. Serum erythropoietin and erythropoiesis in patients with myelodysplastic syndromes.
Bowen DT; Jacobs A; Cotes PM; Lewis TC
Eur J Haematol; 1990 Jan; 44(1):30-2. PubMed ID: 2307217
[TBL] [Abstract][Full Text] [Related]
11. Reticulocyte parameters of delta beta thalassaemia trait, beta thalassaemia trait and iron deficiency anaemia.
Velasco-Rodríguez D; Alonso-Domínguez JM; González-Fernández FA; Villarrubia J; Sopeña M; Abalo L; Ropero P; Martínez-Nieto J; de la Fuente Gonzalo F; Cava F
J Clin Pathol; 2016 Feb; 69(2):149-54. PubMed ID: 26265587
[TBL] [Abstract][Full Text] [Related]
12. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients.
Chuang CL; Liu RS; Wei YH; Huang TP; Tarng DC
Nephrol Dial Transplant; 2003 Feb; 18(2):370-7. PubMed ID: 12543894
[TBL] [Abstract][Full Text] [Related]
13. Effect of subcutaneously administered human recombinant erythropoietin on erythropoiesis in patients with myelodysplasia.
van Kamp H; Prinsze-Postema TC; Kluin PM; den Ottolander GJ; Beverstock GC; Willemze R; Fibbe WE
Br J Haematol; 1991 Aug; 78(4):488-93. PubMed ID: 1911340
[TBL] [Abstract][Full Text] [Related]
14. Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts.
Conte S; Katayama S; Vesterlund L; Karimi M; Dimitriou M; Jansson M; Mortera-Blanco T; Unneberg P; Papaemmanuil E; Sander B; Skoog T; Campbell P; Walfridsson J; Kere J; Hellström-Lindberg E
Br J Haematol; 2015 Nov; 171(4):478-90. PubMed ID: 26255870
[TBL] [Abstract][Full Text] [Related]
15. Marked decreases of total and immature reticulocytes in myelodysplastic syndrome among patients with pancytopenia.
Kabutomori O; Kanakura Y; Iwatani Y
Acta Haematol; 2003; 109(4):212-3. PubMed ID: 12853698
[No Abstract] [Full Text] [Related]
16. The clearance of a single i.v. bolus of recombinant human erythropoietin from the serum of patients with myelodysplastic syndromes and its effects on erythropoiesis.
Bowen D; Ehmer B; Neubert P; Lewis T; Jacobs A
Exp Hematol; 1991 Aug; 19(7):613-6. PubMed ID: 1716588
[TBL] [Abstract][Full Text] [Related]
17. Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes.
Invernizzi R; Pecci A; Travaglino E; Gobbi PG; Malabarba L; Ramajoli I; Ascari E
Br J Haematol; 2002 Jul; 118(1):246-50. PubMed ID: 12100155
[TBL] [Abstract][Full Text] [Related]
18. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
[TBL] [Abstract][Full Text] [Related]
19. Serum stem cell factor concentration in patients with myelodysplastic syndromes.
Bowen D; Yancik S; Bennett L; Culligan D; Resser K
Br J Haematol; 1993 Sep; 85(1):63-6. PubMed ID: 7504511
[TBL] [Abstract][Full Text] [Related]
20. Number and maturation of reticulocytes in various genotypes of thalassaemia as assessed by flow cytometry.
Khuhapinant A; Bunyaratvej A; Tatsumi N; Pribwai M; Fucharoen S
Acta Haematol; 1994; 91(3):119-25. PubMed ID: 8091932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
